Live feed
Filing
SC 13D
SC 13D0001104659-16-120074·Intellia Therapeutics, Inc.
Schedule 13D ownership disclosure
Intellia Therapeutics Inc
Security class unavailable · CUSIP: 45826J105
Event date: 2016-05-05
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 5,573,658
- Percent of class
- 15.4800%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-16-120074
- Form type
- SC 13D
- Filer
- Intellia Therapeutics, Inc.
- CIK
- CIK 1652130
- Filed
- May 11, 2016
- Reporting period
- May 05, 2016
- Description
- Schedule 13D beneficial ownership